GABA (CAS 56-12-2) Market (Updated Version Available)

GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Gamma-Amino Butyric acid (GABA) is an amino acid which acts as a neurotransmitter in the central nervous system. It inhibits nerve transmission in the brain, calming nervous activity. GABA plays an important role in behavior, cognition, and the bodys response to stress. Lower-than-normal levels of GABA in the brain have been linked to schizophrenia, depression, anxiety, and sleep disorders.
At present, there are two ways to produce GABA: chemical synthesis method and biological fermentation method. Among them, biological fermentation method feeding on monosodium glutamate and lactobacillus, is safer and more widely used. The price of GABA produced from monosodium glutamate and lactobacillus is relatively higher. As the limitation of application fields, the market share of chemical synthesis product decreased.
The global GABA (CAS 56-12-2) market is valued at 35 million US$ in 2020 and will reach 48 million US$ by the end of 2026, growing at a CAGR of 4.1% during 2021-2026. The objectives of this study are to define, segment, and project the size of the GABA (CAS 56-12-2) market based on company, product type, end user and key regions.

This report studies the global market size of GABA (CAS 56-12-2) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of GABA (CAS 56-12-2) in these regions.
This research report categorizes the global GABA (CAS 56-12-2) market by top players/brands, region, type and end user. This report also studies the global GABA (CAS 56-12-2) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

This report covers the present status and the future prospects of the global GABA (CAS 56-12-2) market for 2015-2026.
The report offers detailed coverage of GABA (CAS 56-12-2) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading GABA (CAS 56-12-2) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Chemical Synthesis, Biological Fermentation,

Market Segment as follows:
Market by Order Type

Chemical Synthesis
Biological Fermentation
Market size by End User
Pharmaceuticals & Health
Food & Beverage
Animal Feeds
Others

market while maintaining their competitive edge over their competitors. The report offers detailed and crucial information to understand the overall market scenario.

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the GABA (CAS 56-12-2) market for the forecast period 2021 - 2026?
• What are the driving forces in the GABA (CAS 56-12-2) market for the forecast period 2021 - 2026?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the GABA (CAS 56-12-2) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.